A detailed history of Keybank National Association transactions in Amgen Inc stock. As of the latest transaction made, Keybank National Association holds 184,227 shares of AMGN stock, worth $48.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
184,227
Previous 185,839 0.87%
Holding current value
$48.5 Million
Previous $58.1 Million 2.23%
% of portfolio
0.23%
Previous 0.24%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $498,720 - $543,856
-1,612 Reduced 0.87%
184,227 $59.4 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $394,650 - $479,603
1,502 Added 0.81%
185,839 $58.1 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $436,644 - $527,085
1,624 Added 0.89%
184,337 $52.4 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $133,986 - $151,153
524 Added 0.29%
182,713 $52.6 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $495,460 - $615,128
-2,266 Reduced 1.23%
182,189 $49 Million
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $205,913 - $243,488
-961 Reduced 0.52%
184,455 $41 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $474,384 - $578,195
-2,101 Reduced 1.12%
185,416 $44.8 Million
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $513,714 - $652,735
-2,243 Reduced 1.18%
187,517 $49.2 Million
Q3 2022

Oct 27, 2022

SELL
$224.46 - $253.15 $454,531 - $512,628
-2,025 Reduced 1.06%
189,760 $42.8 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $640,912 - $713,223
-2,778 Reduced 1.43%
191,785 $46.7 Million
Q1 2022

Apr 28, 2022

SELL
$219.27 - $242.57 $1.18 Million - $1.3 Million
-5,375 Reduced 2.69%
194,563 $47 Million
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $833,704 - $954,099
-4,192 Reduced 2.05%
199,938 $45 Million
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $961,158 - $1.13 Million
-4,528 Reduced 2.17%
204,130 $43.4 Million
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $2.68 Million - $2.98 Million
-11,492 Reduced 5.22%
208,658 $50.9 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $4.33 Million - $5.05 Million
-19,530 Reduced 8.15%
220,150 $54.8 Million
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $2.42 Million - $2.88 Million
-11,174 Reduced 4.45%
239,680 $55.1 Million
Q3 2020

Oct 29, 2020

SELL
$234.65 - $260.95 $2.61 Million - $2.91 Million
-11,144 Reduced 4.25%
250,854 $63.8 Million
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $137,873 - $169,189
-697 Reduced 0.27%
261,998 $61.8 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $1.17 Million - $1.55 Million
-6,406 Reduced 2.38%
262,695 $53.3 Million
Q4 2019

Feb 05, 2020

SELL
$189.21 - $243.2 $458,077 - $588,787
-2,421 Reduced 0.89%
269,101 $64.9 Million
Q3 2019

Nov 04, 2019

BUY
$174.11 - $208.62 $27,509 - $32,961
158 Added 0.06%
271,522 $52.5 Million
Q2 2019

Aug 01, 2019

SELL
$166.7 - $195.41 $280,889 - $329,265
-1,685 Reduced 0.62%
271,364 $50 Million
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $611,883 - $689,726
-3,383 Reduced 1.22%
273,049 $51.9 Million
Q4 2018

Jan 30, 2019

SELL
$178.4 - $208.25 $1.7 Million - $1.99 Million
-9,553 Reduced 3.34%
276,432 $53.8 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $586,813 - $661,554
-3,167 Reduced 1.1%
285,985 $59.3 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $792,888 - $890,585
-4,775 Reduced 1.62%
289,152 $53.4 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $4.84 Million - $5.66 Million
28,580 Added 10.77%
293,927 $50.1 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $3.34 Million - $3.73 Million
-19,803 Reduced 6.94%
265,347 $46.1 Million
Q3 2017

Nov 02, 2017

SELL
$167.29 - $191.0 $1.06 Million - $1.21 Million
-6,335 Reduced 2.17%
285,150 $53.2 Million
Q2 2017

May 14, 2018

BUY
N/A
1,437 Added 0.5%
291,485 $50.2 Million
Q1 2017

May 14, 2018

BUY
N/A
1,897 Added 0.66%
290,048 $47.6 Million
Q4 2016

May 14, 2018

BUY
N/A
288,151
288,151 $42.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.